PAIN
Volume 145, Issue 3 , Pages 294-303 , October 2009

Sigma-1 receptors regulate activity-induced spinal sensitization and neuropathic pain after peripheral nerve injury

  • Beatriz de la Puente

      Affiliations

    • Department of Pharmacology, Laboratorios Esteve. Av. Mare de Déu de Montserrat, 221. 08041 Barcelona, Spain
    • ,
  • Xavier Nadal

      Affiliations

    • Laboratory of Neuropharmacology, Facultat de Ciències de la Salut i de la Vida, Universitat Pompeu Fabra. Doctor Aguader, 88. 08003 Barcelona, Spain
    • ,
  • Enrique Portillo-Salido

      Affiliations

    • Department of Pharmacology, Laboratorios Esteve. Av. Mare de Déu de Montserrat, 221. 08041 Barcelona, Spain
    • ,
  • Ricard Sánchez-Arroyos

      Affiliations

    • Department of Pharmacology, Laboratorios Esteve. Av. Mare de Déu de Montserrat, 221. 08041 Barcelona, Spain
    • ,
  • Sergio Ovalle

      Affiliations

    • Department of Pharmacology, Laboratorios Esteve. Av. Mare de Déu de Montserrat, 221. 08041 Barcelona, Spain
    • ,
  • Gabriel Palacios

      Affiliations

    • Department of Pharmacology, Laboratorios Esteve. Av. Mare de Déu de Montserrat, 221. 08041 Barcelona, Spain
    • ,
  • Asunción Muro

      Affiliations

    • Department of Pharmacology, Laboratorios Esteve. Av. Mare de Déu de Montserrat, 221. 08041 Barcelona, Spain
    • ,
  • Luz Romero

      Affiliations

    • Department of Pharmacology, Laboratorios Esteve. Av. Mare de Déu de Montserrat, 221. 08041 Barcelona, Spain
    • ,
  • José Manuel Entrena

      Affiliations

    • Department of Pharmacology and Institute of Neuroscience, Faculty of Medicine, Universidad de Granada, Av. de Madrid 11. 18012 Granada, Spain
    • ,
  • José Manuel Baeyens

      Affiliations

    • Department of Pharmacology and Institute of Neuroscience, Faculty of Medicine, Universidad de Granada, Av. de Madrid 11. 18012 Granada, Spain
    • ,
  • José Antonio López-García

      Affiliations

    • Department of Physiology, Faculty of Medicine, Universidad de Alcalá de Henares. Alcalá de Henares, 28871 Madrid, Spain
    • ,
  • Rafael Maldonado

      Affiliations

    • Laboratory of Neuropharmacology, Facultat de Ciències de la Salut i de la Vida, Universitat Pompeu Fabra. Doctor Aguader, 88. 08003 Barcelona, Spain
    • ,
  • Daniel Zamanillo

      Affiliations

    • Department of Pharmacology, Laboratorios Esteve. Av. Mare de Déu de Montserrat, 221. 08041 Barcelona, Spain
    • ,
  • José Miguel Vela

      Affiliations

    • Department of Pharmacology, Laboratorios Esteve. Av. Mare de Déu de Montserrat, 221. 08041 Barcelona, Spain
    • Corresponding Author InformationCorresponding author. Tel.: +34 93 4466244; fax: +34 93 4466220.

Received 24 March 2009 ,Revised 1 May 2009 ,Accepted 12 May 2009.

References 

  1. Alonso G, Phan V, Guillemain I, Saunier M, Legrand A, Anoal M, et al. Immunocytochemical localization of the sigma(1) receptor in the adult rat central nervous system. Neuroscience. 2000;97:155–170
  2. Aydar E, Palmer CP, Klyachko VA, Jackson MB. The sigma receptor as a ligand-regulated auxiliary potassium channel subunit. Neuron. 2002;34:399–410
  3. Baron R. Mechanisms of disease: neuropathic pain–a clinical perspective. Nat Clin Pract Neurol. 2006;2:95–106
  4. Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 1988;33:87–107
  5. Bergeron R, de Montigny C, Debonnel G. Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors. J Neurosci. 1996;16:1193–1202
  6. Brenner GJ, Ji RR, Shaffer S, Woolf CJ. Peripheral noxious stimulation induces phosphorylation of the NMDA receptor NR1 subunit at the PKC-dependent site, serine-896, in spinal cord dorsal horn neurons. Eur J Neurosci. 2004;20:375–384
  7. Cendán CM, Pujalte JM, Portillo-Salido E, Baeyens JM. Antinociceptive effects of haloperidol and its metabolites in the formalin test in mice. Psychopharmacology (Berl). 2005;182:485–493
  8. Cendán CM, Pujalte JM, Portillo-Salido E, Montoliu L, Baeyens JM. Formalin-induced pain is reduced in sigma(1) receptor knockout mice. Eur J Pharmacol. 2005;511:73–74
  9. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 1994;53:55–63
  10. Chien CC, Pasternak GW. Selective antagonism of opioid analgesia by a sigma system. J Pharmacol Exp Ther. 1994;271:1583–1590
  11. Chien CC, Pasternak GW. Sigma antagonists potentiate opioid analgesia in rats. Neurosci Lett. 1995;190:137–139
  12. Ciruela A, Dixon AK, Bramwell S, Gonzalez MI, Pinnock RD, Lee K. Identification of MEK1 as a novel target for the treatment of neuropathic pain. Br J Pharmacol. 2003;138:751–756
  13. Cobos EJ, Baeyens JM, Del Pozo E. Phenytoin differentially modulates the affinity of agonist and antagonist ligands for sigma 1 receptors of guinea pig brain. Synapse. 2005;55:192–195
  14. Cobos EJ, del Pozo E, Baeyens JM. Irreversible blockade of sigma-1 receptors by haloperidol and its metabolites in guinea pig brain and SH-SY5Y human neuroblastoma cells. J Neurochem. 2007;102:812–825
  15. Cobos EJ, Entrena JM, Nieto FR, Cendán CM, Del Pozo E. Pharmacology and therapeutic potential of sigma1 receptor ligands. Curr Neuropharmacol. 2008;6:344–366
  16. Coderre TJ. The role of excitatory amino acid receptors and intracellular messengers in persistent nociception after tissue injury in rats. Mol Neurobiol. 1993;7:229–246[fall-winter]
  17. Dickenson AH, Sullivan AF. Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following C fibre stimulation. Neuropharmacology. 1987;26:1235–1238
  18. Entrena JM, Cobos EJ, Nieto FR, Cendán CM, Gris G, Del Pozo E, et al. Sigma-1 receptors are essential for capsaicin-induced mechanical hypersensitivity: studies with selective sigma-1 ligands and sigma-1 knockout mice. Pain. 2009;143:252–261
  19. Fang L, Wu J, Lin Q, Willis WD. Calcium-calmodulin-dependent protein kinase II contributes to spinal cord central sensitization. J Neurosci. 2002;22:4196–4204
  20. Fontanilla D, Johannessen M, Hajipour AR, Cozzi NV, Jackson MB, Ruoho AE. The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator. Science. 2009;323:934–937
  21. Fukui T, Dai Y, Iwata K, Kamo H, Yamanaka H, Obata K, et al. Frequency-dependent ERK phosphorylation in spinal neurons by electric stimulation of the sciatic nerve and the role in electrophysiological activity. Mol Pain. 2007;16:3–18
  22. Guitart X, Codony X, Monroy X. Sigma receptors: biology and therapeutic potential. Psychopharmacology (Berl). 2004;174:301–319
  23. Hanner M, Moebius FF, Flandorfer A, Knaus HG, Striessnig J, Kempner E, et al. Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proc Natl Acad Sci USA. 1996;93:8072–8077
  24. Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 1988;32:77–88
  25. Hayashi T, Kagaya A, Takebayashi M, Shimizu M, Uchitomi Y, Motohashi N, et al. Modulation by sigma ligands of intracellular free Ca++ mobilization by N-methyl-d-aspartate in primary culture of rat frontal cortical neurons. J Pharmacol Exp Ther. 1995;275:207–214
  26. Hayashi T, Maurice T, Su TP. Ca(2+) signaling via sigma(1)-receptors: novel regulatory mechanism affecting intracellular Ca(2+) concentration. J Pharmacol Exp Ther. 2000;293:788–798
  27. Hayashi T, Su TP. Regulating ankyrin dynamics: roles of sigma-1 receptors. Proc Natl Acad Sci USA. 2001;98:491–496
  28. Hayashi T, Su TP. Sigma-1 receptor chaperones at the ER–mitochondrion interface regulate Ca(2+) signaling and cell survival. Cell. 2007;131:596–610
  29. Hayashi T, Su TP. Sigma-1 receptors (sigma(1) binding sites) form raft-like microdomains and target lipid droplets on the endoplasmic reticulum: roles in endoplasmic reticulum lipid compartmentalization and export. J Pharmacol Exp Ther. 2003;306:718–725
  30. Hayashi T, Su TP. The potential role of sigma-1 receptors in lipid transport and lipid raft reconstitution in the brain: implication for drug abuse. Life Sci. 2005;77:1612–1624
  31. Herrero JF, Laird JM, López-García JA. Wind-up of spinal cord neurones and pain sensation: much ado about something?. Prog Neurobiol. 2000;61:169–203
  32. Hua XY, Chen P, Yaksh TL. Inhibition of spinal protein kinase C reduces nerve injury-induced tactile allodynia in neuropathic rats. Neurosci Lett. 1999;276:99–102
  33. Igwe OJ, Ning L. Regulation of the second-messenger systems in the rat spinal cord during prolonged peripheral inflammation. Pain. 1994;58:63–75
  34. Ji RR, Baba H, Brenner GJ, Woolf CJ. Nociceptive-specific activation of ERK in spinal neurons contributes to pain hypersensitivity. Nat Neurosci. 1999;2:1114–1119
  35. Ji RR, Woolf CJ. Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain. Neurobiol Dis. 2001;8:1–10
  36. Kawasaki Y, Kohno T, Zhuang ZY, Brenner GJ, Wang H, Van Der Meer C, et al. Ionotropic and metabotropic receptors, protein kinase A, protein kinase C, and Src contribute to C-fiber induced ERK activation and cAMP response element-binding protein phosphorylation in dorsal horn neurons, leading to central sensitization. J Neurosci. 2004;24:8310–8321
  37. Kim HW, Kwon YB, Roh DH, Yoon SY, Han HJ, Kim KW, et al. Intrathecal treatment with sigma1 receptor antagonists reduces formalin-induced phosphorylation of NMDA receptor subunit 1 and the second phase of formalin test in mice. Br J Pharmacol. 2006;148:490–498
  38. Kim HW, Roh DH, Yoon SY, Seo HS, Kwon YB, Han HJ, et al. Activation of the spinal sigma-1 receptor enhances NMDA-induced pain via PKC- and PKA-dependent phosphorylation of the NR1 subunit in mice. Br J Pharmacol. 2008;154:1125–1134
  39. King M, Pan YX, Mei J, Chang A, Xu J, Pasternak GW. Enhanced kappa-opioid receptor-mediated analgesia by antisense targeting the sigma1 receptor. Eur J Pharmacol. 1997;331:R5–R6
  40. Kitaichi K, Chabot JG, Moebius FF, Flandorfer A, Glossmann H, Quirion R. Expression of the purported sigma(1) (sigma(1)) receptor in the mammalian brain and its possible relevance in deficits induced by antagonism of the NMDA receptor complex as revealed using an antisense strategy. J Chem Neuroanat. 2000;20:375–387
  41. Langa F, Codony X, Tovar V, Lavado A, Giménez E, Cozar P, et al. Generation and phenotypic analysis of sigma receptor type I (sigma 1) knockout mice. Eur J Neurosci. 2003;18:2188–2196
  42. Ma W, Quirion R. The ERK/MAPK pathway, as a target for the treatment of neuropathic pain. Expert Opin Ther Targets. 2005;9:699–713
  43. Malmberg AB, Basbaum AI. Partial sciatic nerve injury in the mouse as a model of neuropathic pain: behavioral and neuroanatomical correlates. Pain. 1998;76:215–222
  44. Martina M, Turcotte ME, Halman S, Bergeron R. The sigma-1 receptor modulates NMDA receptor synaptic transmission and plasticity via SK channels in rat hippocampus. J Physiol. 2007;578:143–157
  45. Martinez-Gomez J, Lopez-Garcia JA. Simultaneous assessment of the effects of L-type current modulators on sensory and motor pathways of the mouse spinal cord in vitro. Neuropharmacology. 2007;53:464–471
  46. Martin-Fardon R, Maurice T, Aujla H, Bowen WD, Weiss F. Differential effects of sigma1 receptor blockade on self-administration and conditioned reinstatement motivated by cocaine vs natural reward. Neuropsychopharmacology. 2007;32:1967–1973
  47. Maurice T. Neurosteroids and sigma1 receptors, biochemical and behavioral relevance. Pharmacopsychiatry. 2004;37:S171–S182
  48. Mei J, Pasternak GW. Sigma1 receptor modulation of opioid analgesia in the mouse. J Pharmacol Exp Ther. 2002;300:1070–1074
  49. Meller ST, Dykstra CL, Gebhart GF. Investigations of the possible role for carbon monoxide (CO) in thermal and mechanical hyperalgesia in the rat. Neuroreport. 1994;5:2337–2341
  50. Mendell LM. Physiological properties of unmyelinated fiber projection to the spinal cord. Exp Neurol. 1966;16:316–332
  51. Monnet FP, Debonnel G, Junien JL, De Montigny C. N-methyl-d-aspartate-induced neuronal activation is selectively modulated by sigma receptors. Eur J Pharmacol. 1990;179:441–445
  52. Monnet FP, Maurice T. The sigma1 protein as a target for the non-genomic effects of neuro(active)steroids: molecular, physiological, and behavioral aspects. J Pharmacol Sci. 2006;100:93–118
  53. Monnet FP, Morin-Surun MP, Leger J, Combettes L. Protein kinase C-dependent potentiation of intracellular calcium influx by sigma1 receptor agonists in rat hippocampal neurons. J Pharmacol Exp Ther. 2003;307:705–712
  54. Monnet FP. Sigma-1 receptor as regulator of neuronal intracellular Ca2+: clinical and therapeutic relevance. Biol Cell. 2005;97:873–883
  55. Morin-Surun MP, Collin T, Denavit-Saubié M, Baulieu EE, Monnet FP. Intracellular sigma1 receptor modulates phospholipase C and protein kinase C activities in the brainstem. Proc Natl Acad Sci USA. 1999;96:8196–8199
  56. Mtchedlishvili Z, Kapur J. A presynaptic action of the neurosteroid pregnenolone sulfate on GABAergic synaptic transmission. Mol Pharmacol. 2003;64:857–864
  57. Nieto FR, Entrena JM, Cendán CM, Pozo ED, Vela JM, Baeyens JM. Tetrodotoxin inhibits the development and expression of neuropathic pain induced by paclitaxel in mice. Pain. 2008;137:520–531
  58. Palacios G, Muro A, Vela JM, Molina-Holgado E, Guitart X, Ovalle S, et al. Immunohistochemical localization of the sigma1-receptor in oligodendrocytes in the rat central nervous system. Brain Res. 2003;961:92–99
  59. Palacios G, Muro A, Verdú E, Pumarola M, Vela JM. Immunohistochemical localization of the sigma1 receptor in Schwann cells of rat sciatic nerve. Brain Res. 2004;1007:65–70
  60. Pan YX, Mei J, Xu J, Wan BL, Zuckerman A, Pasternak GW. Cloning and characterization of a mouse sigma1 receptor. J Neurochem. 1998;70:2279–2285
  61. Peeters M, Romieu P, Maurice T, Su TP, Maloteaux JM, Hermans E. Involvement of the sigma 1 receptor in the modulation of dopaminergic transmission by amantadine. Eur J Neurosci. 2004;19:2212–2220
  62. Prasad PD, Li HW, Fei YJ, Ganapathy ME, Fujita T, Plumley LH, et al. Exon-intron structure, analysis of promoter region, and chromosomal localization of the human type 1 sigma receptor gene. J Neurochem. 1998;70:443–451
  63. Roh DH, Kim HW, Yoon SY, Seo HS, Kwon YB, Kim KW, et al. Intrathecal injection of the sigma(1) receptor antagonist BD1047 blocks both mechanical allodynia and increases in spinal NR1 expression during the induction phase of rodent neuropathic pain. Anesthesiology. 2008;109:879–889
  64. Roh DH, Kim HW, Yoon SY, Seo HS, Kwon YB, Kim KW, et al. Intrathecal administration of sigma-1 receptor agonists facilitates nociception: involvement of a protein kinase C-dependent pathway. J Neurosci Res. 2008;86:3644–3654
  65. Song XS, Cao JL, Xu YB, He JH, Zhang LC, Zeng YM. Activation of ERK/CREB pathway in spinal cord contributes to chronic constrictive injury-induced neuropathic pain in rats. Acta Pharmacol Sin. 2005;26:789–798
  66. Soriani O, Le Foll F, Galas L, Roman F, Vaudry H, Cazin L. The sigma-ligand (+)-pentazocine depresses M current and enhances calcium conductances in frog melanotrophs. Am J Physiol. 1999;277:E73–E80
  67. Su TP, Hayashi T. Understanding the molecular mechanism of sigma-1 receptors: towards a hypothesis that sigma-1 receptors are intracellular amplifiers for signal transduction. Curr Med Chem. 2003;10:2073–2080
  68. Treede RD, Meyer RA, Raja SN, Campbell JN. Peripheral and central mechanisms of cutaneous hyperalgesia. Prog Neurobiol. 1992;38:397–421
  69. Willis WD. Role of neurotransmitters in sensitization of pain responses. Ann NY Acad Sci. 2001;933:142–156
  70. Woolf CJ, Thompson SW. The induction and maintenance of central sensitization is dependent on N-methyl-d-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain. 1991;44:293–299
  71. Xin WJ, Gong QJ, Xu JT, Yang HW, Zang Y, Zhang T, et al. Role of phosphorylation of ERK in induction and maintenance of LTP of the C-fiber evoked field potentials in spinal dorsal horn. J Neurosci Res. 2006;84:934–943
  72. Zamanillo D, Andreu F, Ovalle S, Pérez MP, Romero G, Farré AJ, et al. Up-regulation of sigma(1) receptor mRNA in rat brain by a putative atypical antipsychotic and sigma receptor ligand. Neurosci Lett. 2000;282:169–172
  73. Zhuang ZY, Gerner P, Woolf CJ, Ji RR. ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain. 2005;114:149–159
  74. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 1983;16:109–110

PII: S0304-3959(09)00278-4

doi: 10.1016/j.pain.2009.05.013

PAIN
Volume 145, Issue 3 , Pages 294-303 , October 2009

Article Tools

* Image Usage & Resolution